What is the process by which a drug is transported by the bloodstream to receptor sites?

Alvarado F, Van Os CH (1986) (eds) Ion gradient-coupled transport. Elsevier Science Publishers, Amsterdam, pp 442

Google Scholar 

Atanasova S, von Ahsen N, Dimitrov T, Armstrong V, Oellerich M, Toncheva D (2004) MDR1 haplotypes modify BEN disease risk: a study in Bulgarian patients with Balkan endemic nephropathy compared to healthy controls. Nephron Exp Nephrol 96:7–13

Google Scholar 

Athayde AL, Ivory CF (1985) Electrical pumping in carrier-mediated membrane transport. J Membr Sci 24:309–323

CAS  Google Scholar 

Ayrton A, Morgan P (2001) Role of transport proteins in drug absorption, distribution and excretion. Xenobiotica 31:469–497

PubMed  CAS  Google Scholar 

Bilej M, Vetvicka V (1989) The transmembrane and intracellular transport of drugs: interactions with the cytosceletal network. Crit Rev Ther Drug Carrier Syst 6:613–691

PubMed  CAS  Google Scholar 

Bolhuis H, van Veen HW, Poolman B, Driessen AJ, Konings WN (1997) Mechanisms of multidrug transporters. FEMS Microbiol Rev 21:55–84

PubMed  CAS  Google Scholar 

Borst P, Oude Elferink R (2002) Mammalian ABC transporters in health and disease. Annu Rev Biochem 71:537–592

PubMed  CAS  Google Scholar 

Brant SR, Panhuysen CI, Nicolae D, Reddy DM, Bonen DK, Karaliukas R, Zhang L, Swanson E, Datta LW, Moran T, Ravenhill G, Duerr RH, Achkar JP, Karban AS, Cho JH (2003) MDR1 Ala893 polymorphism is associated with inflammatory bowel disease. Am J Hum Genet 73:1282–1292

PubMed  CAS  Google Scholar 

Brodie BB (1964) Physico-chemical factors in drug absorption. In: Binns TB (ed) Absorption and distribution of drugs. Livingstone, Edinburgh, pp 16–48

Google Scholar 

Brodie BB, Hogben CAM (1957) Some physico-chemical factors in drug action. J Pharmacy Pharmacol 9:345–380

CAS  Google Scholar 

Burckhardt BC, Burckhardt G (2003) Transport of organic anions across the basolateral membrane of proximal tubule cells. Rev Physiol Biochem Pharmacol 146:95–158

PubMed  CAS  Google Scholar 

Burckhardt G, Wolff NA (2000) Structure of renal organic anion and cation transporters. Am J Physiol Renal Physiol 278:F853–F866

PubMed  CAS  Google Scholar 

Caldwell PC (1956) The effects of certain metabolic inhibitors on the phosphate esters of the squid giant axon. J Physiol (London) 132:35

CAS  Google Scholar 

Caldwell PC (1960) The phosphorus metabolism of squid axons and its relationship to the active transport of sodium. J Physiol (London) 152:545–560

CAS  Google Scholar 

Carafoli E, Scarpa A (1982) (eds) Transport-ATPases. Ann N Y Acad Sci, New York (402):604

Google Scholar 

Catania VA, Sanchez Pozzi EJ, Luquita MG, Ruiz ML, Villanueva SS, Jones B, Mottino AD (2004) Co-regulation of expression of phase II metabolizing enzymes and multidrug resistance-associated protein 2. Ann Hepatol 3:11–17

PubMed  Google Scholar 

Chan LMS, Lowes S, Hirst BH (2004) The ABCs of drug transport in intestine and liver: efflux proteins limiting drug absorption and bioavailability. Eur J Pharmaceut Sci 21:25–51

CAS  Google Scholar 

Chandra P, Brouwer KL (2004) The complexities of hepatic drug transport: current knowledge and emerging concepts. Pharm Res 21:719–735

PubMed  CAS  Google Scholar 

Crane RK, Krane SM (1959) Studies on the mechanism of intestinal active transport of sugars. Biochim Biophys Acta 31:397–401

PubMed  CAS  Google Scholar 

Dahlquist R, Ejvinsson G, Schenk-Gustaffson K (1980) Effect of quinidine on plasma concentration and renal clearance of digoxin. A clinically important drug interaction. Brit J Clin Pharmacol 9:413–418

Google Scholar 

Daniel H (2004) Molecular and integrative physiology of intestinal peptide transport. Annu Rev Physiol 66:361–384

PubMed  CAS  Google Scholar 

Daniel H, Rubio-Aliaga I (2003) An update on renal peptide transporters. Am J Physiol Renal Physiol 284:F885–F892

PubMed  CAS  Google Scholar 

Dean M, Rzhetsky A, Allikmets R (2001) The human ATP-binding cassette (ABC) transporter superfamily. Genome Res 11:1156–1166

PubMed  CAS  Google Scholar 

Delgoda R, Westlake AC (2004) Herbal interactions involving cytochrome p450 enzymes: a mini review. Toxicol Rev 23:239–249

PubMed  CAS  Google Scholar 

DeVree J, Jacquemin E, Sturm E, Creteil D, Bosma PJ, Aten J, DeLeuze JF, Desrochers M, Burdelski M, Bernard O, Oude Elferink RP, Hadchouel M (1998) Mutations in the MDR3 gene cause progessive familial intahepatic cholestasis. Proc Natl Acad Sci USA 95:282–287

CAS  Google Scholar 

Diamond JM,Wright EM (1969) Biological membranes: the physical basis of ion and nonelectrolyte selectivity. Annu Rev Physiol 31:581–646

PubMed  CAS  Google Scholar 

Dietrich CG, Geier A, Oude Elferink RPJ (2003) ABC or oral bioavailability: transporters as gatekeepers in the gut. Gut 52:1788–1795

PubMed  CAS  Google Scholar 

Doering W (1979) Quinidine-digoxin interaction: Pharmacokinetics, underlying mechanism and clinical implications. N Engl J Med 301:400–404

Article  PubMed  CAS  Google Scholar 

Donner MG, Keppler D (2001) Up-regulation of basolateral multidrug resistance protein 3 (Mrp3) in cholestatic rat liver. Hepatology 34:351–359

PubMed  CAS  Google Scholar 

Drescher S, Schaeffeler E, Hitzl M, Hofmann U, Schwab M, Brinkmann U, Eichelbaum M, Fromm MF (2002) MDR1 gene polymorphisms and disposition of the P-glycoprotein substrate fexofenadine. Br J Clin Pharmacol 53:526–534

PubMed  CAS  Google Scholar 

Drescher S, Glaser H, Mürdter T, Hitzl M, Eichelbaum M, Fromm MF (2003) P-glycoprotein-mediated intestinal and biliary digoxin transport in humans. Clin Pharmacol Ther 73:223–231

PubMed  CAS  Google Scholar 

Dresser MJ, Leabman MK, Giacomini KM (2001) Transporters involved in the elimination of drugs in the kidney: organic anion transporters and organic cation transporters. Pharmaceut Sci 90:397–420

CAS  Google Scholar 

Dresser GK, Bailey DG, Leake BF, Schwarz UI, Dawson PA, Freeman DJ, Kim RB (2002) Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine. Clin Pharmacol Ther 71:11–20

PubMed  CAS  Google Scholar 

Drozdzik M, Bialecka M, Mysliwiec K, Honczarenko K, Stankiewicz J, Sych Z (2003) Polymorphism in the P-glycoprotein drug transporter MDR1 gene: a possible link between environmental and genetic factors in Parkinson’s disease. Pharmacogenetics 13:259–263

PubMed  CAS  Google Scholar 

Elleroy JC, Lew VL (1977) (eds) Membrane transport in red cells. Academic Press, New York, pp 469

Google Scholar 

Fardel O, Jigorel E, Le Vee M, Payen L (2005) Physiological, pharmacological and clinical features of the multidrug resistance protein 2. Biomed Pharmacother 59:104–114

PubMed  CAS  Google Scholar 

Fehrenbach T, Cui Y, Faulstich H, Keppler D (2003) Characterization of the transport of the bicyclic peptide phalloidin by human hepatic transport proteins. Naunyn-Schmiedeberg’s Arch Pharmacol 368:415–420

CAS  Google Scholar 

Fromm MF (2004) Importance of P-glycoprotein at blood-tissue barriers. Trends Pharmacol Sci 25:423–429

PubMed  CAS  Google Scholar 

Fromm MF, Kim RB, Stein CM, Wilkinson GR, Roden DM (1999) Inhibition of P-glycoprotein-mediated drug transport: a unifying mechanism to explain the interaction between digoxin and quinidine. Circulation 99:552–557

PubMed  CAS  Google Scholar 

Gao B, St Pierre MV, Stieger B, Meier PJ (2004) Differential expression of bile salt and organic anion transporters in developing rat liver. J Hepatol 41:202–208

Google Scholar 

Gerok W, Sickinger K (1973) (eds) Drugs and the liver. Schattauer Verlag, Stuttgart, pp 441

Google Scholar 

Geyer J, Döring B, Godoy JR, Moritz A, Petzinger E (2005a) Development of a PCR-based diagnostic test detecting a nt230(del4) MDR1 mutation in dogs: verification in a moxidectin-sensitive Australian Shepherd. J Vet Pharmacol Ther 28:95–99

PubMed  CAS  Google Scholar 

Geyer J, Döring B, Godoy JR, Moritz A, Petzinger E (2005b) Frequency of the nt230(del4) MDR1 mutation in Collies and related dog breeds from Germany. J Vet Pharmacol Ther 28:545–551

PubMed  CAS  Google Scholar 

Geyer J, Wilke T, Petzinger E (2006) The solute carrier family SLC10: more than a family of bile acid transporters regarding function and phylogenetic relationships. Naunyn-Schmiedeberg’s Arch Pharmacol, this issue

Gilles-Baillieu M, Gilles R (1983) (eds) Intestinal transport: fundamental and comparative aspects. Springer-Verlag, Berlin Heidelberg New York, pp 375

Google Scholar 

Gillette JR (1963) Metabolism of drugs and other foreign compounds by enzymatic mechanisms. Progr Drug Res 6:11–75

CAS  Google Scholar 

Grammatté T, Oertel R (1999) Intestinal secretion of intravenous talinolol is inhibited by luminal R-verapamil. Clin Pharmacol Ther 66:239–245

Google Scholar 

Grammatté T, Oertel R, Terhaa, B, Kirch W (1996) Direct demonstration of small intestinal secretion and side-dependent absorption of the β-blocker talinolol in human. Clin Pharmacol Ther 59:541–549

Google Scholar 

Greiner B, Eichelbaum M, Fritz P, Kreichgauer HP, von Richter O, Zundler J, Kroemer HK (1999) The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin. J Clin Invest 104:147–153

PubMed  CAS  Google Scholar 

Greger R, Lang F, Silbernagl S (1981) (eds) Renal transport of organic substances. Springer-Verlag, Berlin Heidelberg New York, pp 314

Google Scholar 

Gründemann D, Gorboulev V, Gambaryan S, Veyhl M, Koepsell H (1994) Drug excretion mediated by a new prototype of polyspecific transporter. Nature 372:549–552

PubMed  Google Scholar 

Habig WH, Pabst MJ, Fleischner G, Gatmaitan Z, Arias IM, Jacobvy WB (1974) The identity of glutathione S-transferase B with ligandin, a major binding protein of liver. Proc Natl Acad Sci USA 71:3879–3882

PubMed  CAS  Google Scholar 

Hagenbuch B, Meier PJ (2003) The superfamily of organic anion transporting polypeptides. Biochim Biophys Acta 1609:1–18

PubMed  CAS  Google Scholar 

Haimeur A, Conseil G, Geeley RG, Cole SP (2004) The MRP-related and BCRP/ABCG2 multidrug resitance proteins: biology, substrate specificity and regulation. Curr Drug Metab 5:21–53

PubMed  CAS  Google Scholar 

Hediger MA, Coady MJ, Ikeda TS, Wright EM (1987) Expression cloning and cDNA sequencing of the Na+/glucose cotransporter. Nature (London) 330:379–381

CAS  Google Scholar 

Hediger MA, Romero MF, Peng JB, Rolfs A, Takanaga H, Bruford EA (2004) The ABCs of solute carriers: physiological, pathological, and therapeutic implications of human membrane transport proteins. Pfluegers Arch 447:465–468

CAS  Google Scholar 

Heinz E (1972) (eds) Na-linked transport of organic solutes. The coupling between electrolyte and nonelectrolyte transport in cells. Springer-Verlag, Berlin Heidelberg New York, pp 201

Google Scholar 

Heinz E (1978) (eds) Mechanics and energetics of biological transport. Springer-Verlag, Berlin Heidelberg New York, pp 159

Google Scholar 

Hoffmann U, Kroemer HK (2004) The ABC transporters MDR1 and MRP2: multiple functions in disposition of xenobiotics and drug resistance. Drug Metab Rev 86:669–701

Google Scholar 

Hoffmeyer S, Burk O, von Richter O, Arnold H P, Brockmöller J, Johne A, Cascorbi I, Gerloff T, Roots I, Eichelbaum M, Brinkmann U (2000) Functional polymorphisms of the human multidrug-resitance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Nat Acad Sci U S A 97:3473–3478

CAS  Google Scholar 

Hogben CAM, Tocco DJ, Brodie BB, Schanker LS (1959) On the mechanism of intestinal drug absorption of drugs. J Pharmacol Exp Ther 125:275–282

PubMed  CAS  Google Scholar 

Homolya L, Varadi A, Sarkadi B (2003) Multidrug resitance-assiciated proteins: export pumps for conjugates with glutathione, glucuronate or sulfate. Biofactors 17:103–114

PubMed  CAS  Google Scholar 

Hsiang B, Zhu Y, Wang Z, Wu Y, Sasseville V, Yang WP, Kirchgessner TG (1999) A novel human hepatic organic anion transporting polypeptide (OATP2) Identification of a liver-specific human organic anion transporting polypeptide and identification of rat and human hydroxymethylglutaryl-CoA reductase inhibitor transporters. J Biol Chem 274:37161–37168

PubMed  CAS  Google Scholar 

Ieiri I, Takane H, Otsubo K (2004) The MDR1 (ABCB1) gene polymorphism and its clinical implications. Clin Pharmacokinet 43:553–576

PubMed  CAS  Google Scholar 

Iida A, Saito S, Sekine A, Mishima C, Kondo K, Kitamura Y, Harigae S, Osawa S, Nakamura Y (2001) Catalog of 258 single-nucleotide polymorphisms (SNPs) in genes encoding three organic anion transporters, three organic anion transporting polypeptides, and three NADH : ubichinone oxidoreductase flavoproteins. J Hum Genet 46:668–683

PubMed  CAS  Google Scholar 

Ito K, Iwatsuro T, Kanamitsu S, Ueda K, Suzuki H, Sugiyama Y (1998) Prediction of pharmacokinetic alterations caused by drug-drug interactions: metabolic interaction in the liver. Pharmacol Rev 50:387–411

PubMed  CAS  Google Scholar 

Jackson MJ (1987) Drug transport across gastrointestinal epithelia. In: LR Johnson (ed) Physiology of the gastrointestinal tract. Raven Press, New York, pp 1597–1621

Google Scholar 

Jacquemin E, Hagenbuch B, Stieger B, Wolkoff AW, Meier PJ (1994) Expression cloning of a rat liver Na(+)-independent organic anion transporter. Proc Natl Acad Sci USA 91:133–137

PubMed  CAS  Google Scholar 

Juliano RL, Ling V (1976) A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 455:152–162

PubMed  CAS  Google Scholar 

Jansen PLM (2001) Hereditary defects of hepatobiliary transport. In: Matern S, Boyer JL, Keppler D, Meier-Abt PJ (eds) Hepatobiliary transport: from bench to bedside. Kluwer Acad. Publ., Dordrecht, pp 91–97

Google Scholar 

Kafka A, Sauer G, Jaeger C, Grundmann R, Kreienberg R, Zeillinger R, Deissler H (2003) Polymorphism C3435T of the MDR-1 gene predicts response to preoperative chemotherapy in locally advanced breast cancer. Int J Oncol 22:1117–1121

PubMed  CAS  Google Scholar 

Keynes RD (1961) The energy source for active transport in nerve and muscle. In: A Kleinzeller, A Kotyk (eds) Membrane transport and metabolism. Academic Press, London, pp 131–139

Google Scholar 

Kilby JM, Hill A, Buss N (2002) The effect of ritonavir on saquinavir plasma concentration is independent of ritonavir dosage: combined analysis of pharmacokinetic data from 97 subjects. HIV Med 3:97–104

PubMed  CAS  Google Scholar 

Kim RB (2004) 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins) and genetic variability (single nucleotide polymorphisms) in a hepatic drug uptake transporter: what’s it all about? Clin Pharmacol Ther 75:381–385

PubMed  CAS  Google Scholar 

Kim RB, Fromm MF, Wandel C, Leake B, Wood AJJ, Roden DM, Wilkinson GR (1998) The drug transporter p-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors. J Clin Invest 101:289–294

PubMed  CAS  Google Scholar 

Klaassen CD, Watkins JB (1984) Mechanisms of bile formation, hepatic uptake, and biliary excretion. Pharmacol Rev 36:1–67

PubMed  CAS  Google Scholar 

Koepsell H, Endou H (2004) The SLC22 drug transporter family. Pflügers Arch 447:666–676

PubMed  CAS  Google Scholar 

König J, Rost D, Cui Y, Keppler D (1999) Characterisation of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane. Hepatology 29:1156–1163

PubMed  Google Scholar 

König J, Seithel A, Gradhand U, Fromm MF (2006) Pharmacogenomics of human OATP transporters. Naunyn-Schmiedeberg’s Arch Pharmacol, this issue

Kramer M, Lauterbach F (1977) (eds) Intestinal permeation. Excerpta Medica, Amsterdam, pp 449

Google Scholar 

Kramer W, Wess G (1996) Bile acid transport systems as pharmaceutical targets. Eur J Clin Invest 26:715–732

PubMed  CAS  Google Scholar 

Kramer W, Wess G, Schubert G, Bickel M, Girbig F, Gutjahr U, Kowalewski S, Baringshaus K-H, Ehnsen A, Glombik H, Müllner S, Neckermann G, Schulz S, Petzinger E (1992) Liver-specific drug trageting by coupling with bile acids. J Biol Chem 267:18598–18604

PubMed  CAS  Google Scholar 

Kramer W, Sauber K, Baringhaus K-H, Kurz M, Stengelin S, Lange G, Corsiero D, Girbig F, König W, Weyland C (2001) Identification of the bile acid-binding site of the ileal lipid-binding protein by photoaffinty labelling, matrix-assisted laser desorption ionization-mass spectrometry, and NMR structure. J Biol Chem 276:7291–7301

PubMed  CAS  Google Scholar 

Krusekopf S, Roots I (2005) St. John’s wort and its constituent hyperforin concordantly regulate expression of genes encoding enzymes involved in basic cellular pathways. Pharmacogenetics 15:817–829, Genomics

CAS  Google Scholar 

Kubitz R, Keitel V, Häussinger D (2005) Inborn errors of biliary canalicular transport systems. Meth Enzymol 400:558–569

PubMed  CAS  Google Scholar 

Kullak-Ublick GA, Beuers U, Paumgartner G (2000) Hepatobiliary transport. J Hepatol 32:3–18

PubMed  CAS  Google Scholar 

Kullak-Ublick GA, Stieger B, Meier PJ (2004) Enterohepatic bile salt transporters in normal physiology and liver disease. Gastroenterology 126:322–342

PubMed  CAS  Google Scholar 

LeFevre PG (1948) Evidence of active transfer of certain non-electrolytes across the human red cell membrane. J Gen Physiol 31:505–507

CAS  PubMed  Google Scholar 

LeFevre PG (1975) The present state of the carrier hypothesis. In: Bronner F, Kleinzeller A (eds) Current topics in membranes and transport. Academic Press, London, pp 109–215

Google Scholar 

Leslie EM, Deeley RG, Cole SP (2001) Toxicological relevance of the multidrug resistance protein 1, MRP1 (ABCC1) and related transportes. Toxicology 167:3–23

PubMed  CAS  Google Scholar 

Leslie EM, Deeley RG, Cole SP (2005) Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2 and BCRP (ABCG2) in tissue defense. Toxicol Appl Pharmacol 204:216–237

PubMed  CAS  Google Scholar 

Levi AJ, Gatmaitan Z, Arias IM (1969) Two hepatic cytoplasmic protein fractions, Y and Z, and their possible role in the hepatic uptake of bilirubin, sulfobromophthalein, and other anions. J Clin Invest 48:2156–2167

PubMed  CAS  Google Scholar 

Liu L, Pang KS (2005) The roles of transporters and enzymes in hepatic drug processing. Drug Metab Dispos 33:1–9

PubMed  Google Scholar 

Lloyd JB (2000) Lysosome membrane permeability: implications for drug delivery. Adv Drug Deliv Rev 41:189–200

PubMed  CAS  Google Scholar 

Maisonnette F, Abita T, Barriere E, Pichon N, Vincensini JF, Descottes B (2005) The MDR3 gene mutation: a rare cause of progressive familial intrahepatic cholestasis (PFIC). Ann Chir 130:581–583

PubMed  CAS  Google Scholar 

Mannel M (2004) Drug interactions with St John’s wort: mechanisms and clinical implications. Drug Saf 27:773–797

PubMed  CAS  Google Scholar 

Mealey KL, Bentjen SA, Gay JM, Cantor GH (2001) Ivermectin sensitivity in collies is associated with a deletion mutation in the mdr1 gene. Pharmacogenetics 11:727–733

PubMed  CAS  Google Scholar 

Meijer DK (1993) Drug targeting to the liver with bile acids: the “Trojan horse” resurrected? Hepatology 17:945–948

PubMed  CAS  Google Scholar 

Milne RW, Larsen LA, Jorgensen KL, Bastlund JF, Stretch GL, Evans AM (2000) Hepatic disposition of fexofenadine: influence of the transport inhibitors erythromycin and dibromosulphothalein. Pharmaceutical Res 17:1511–1515

CAS  Google Scholar 

Mizuno N, Niwa T, Yotsumoto Y, Sugiyama Y (2003) Impact of drug transporter studies on drug discovery and development. Pharmacol Rev 55:425–461

PubMed  CAS  Google Scholar 

Müller M, Jansen PLM (1998) The secretory step of the liver: new aspects of hepatobiliary transport. J Hepatol 28:344–354

PubMed  Google Scholar 

Murray JW, Wolkoff AW (2003) Roles of the cytoskeleton and motor proteins in endocytic sorting. Adv Drug Deliv Rev 55:1385–1403

PubMed  CAS  Google Scholar 

Niemi M, Schaeffeler E, Lang T, Fromm MF, Neuvonen M, Kyrklund C, Backman J T, Kerb R, Schwab M, Neuvonen PJ, Eichelbaum M, Kivistö KJ (2004) High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C (OATP-C, SCLO1B1). Pharmacogenetics 14:429–440

PubMed  CAS  Google Scholar 

Niemi M, Neuvonen PJ, Hofmann U, Backman JT, Schwab M, Lütjohann D, von Bergmann K, Eichelbaum M, Kivistö KT (2005a) Acute effects of pravastatin on cholesterol synthesis are associated with SCLO1B1 (encoding OATP1B1) haplotype *17. Pharmacogen Genom 15:303–309

Article  CAS  Google Scholar 

Niemi M, Kivistö KT, Hofmann U, Schwab M, Eichelbaum M, Fromm M (2005b) Fexofenadine pharmacokinetics are associated with a polymorphism of the SCLO1B1 gene (encoding OATP1B1). Br J Clin Pharmacol 59:602–604

PubMed  CAS  Google Scholar 

Nozawa T, Nakajima M, Tamai I, Noda K, Nezu JI, Sai Y, Tsuji A, Yokoi T (2002) Genetic polymorphisms of human organic anion transporters OATP-C (SLC21A6) and OATP-B (SLC21A9): allele frequencies in the Japanese population and functional studies. J Pharmacol Exp Ther 302:804–813

PubMed  CAS  Google Scholar 

Ogawa K, Suzuki H, Hirohashi T, Ishikawa T, Meier PJ, Hirose K, Akizawa T, Yoshioka M, Sugiyama Y (2000) Characterization of inducible nature of MRP3 in rat liver. Am J Physiol Gastrointest Liver Physiol 278:G438–G446

PubMed  CAS  Google Scholar 

Ohashi M, Sano N, Takikawa H (2002) Effects of phalloidin on the biliary excretion of cholephilic compounds in rats. Pharmacology 66:31–35

PubMed  CAS  Google Scholar 

Paul AJ, Tranquilli WJ, Seward RL, Todd KS, DiPietro JA (1987) Clinical observations in collies given ivermectin orally. Am J Vet Res 48:684–685

PubMed  CAS  Google Scholar 

Pauli-Magnus C, Meier PJ (2004) Pharmacogenetics of hepatocellular transporters. Pharmacogenetics 13:189–198

Google Scholar 

Paulusma LC, Oude Elferink RP (1997) The canalicular multispecific anion transporter and conjugated hyperbilirubinemia in rat and man. J Mol Med 75:420–428

PubMed  CAS  Google Scholar 

Pedersen KE, Christansen BD, Klittgaard NA, Nielsen-Kudsk F (1983) Effect of quinidine of digoxin bioavailability. Eur J Clin Pharmacol 24:41–47

PubMed  CAS  Google Scholar 

Petzinger E (1981) Competitive inhibition of the uptake of demethylphalloin by cholic acid in isolated hepatocytes. Evidence for a transport competition rather than a binding competition. Naunyn-Schmiedeberg’s Arch Pharmacol 316:345–349

CAS  Google Scholar 

Petzinger E (1994) Transport of organic anions in the liver. An update on bile acid, fatty acid, monocarboxylate, anionic amino acid, cholephilic organic anion, and anionic drug transport. Rev Physiol Biochem Pharmacol 123:47–211

Article  PubMed  CAS  Google Scholar 

Petzinger E, Ziegler K, Frimmer M (1979) Inhibition of 3H-demethylphalloin uptake in isolated rat hepatocytes under various experimental conditions. Naunyn-Schmiedeberg’s Arch Pharmacol 307:275–281

CAS  Google Scholar 

Petzinger E, Kinne RKH, Sies H (1989) (eds) Hepatic transport of organic substances. Springer-Verlag, Berlin Heidelberg New York, pp 435

Google Scholar 

Petzinger E, Nickau L, Horz JA, Schulz S, Wess G, Ehnsen A, Falk E, Baringhaus K-H, Glombik H, Hoffmann A, Müllner S, Nekermann G, Kramer W (1995) Hepatobiliary transport of hepatic 3-hydroxy-3-methylglutaryl Coenzyme A reductase inhibitors conjugated with bile acids. Hepatology 22:1801–1811

PubMed  CAS  Google Scholar 

Pritchard JB, Miller DS (1993) Mechanisms mediating renal secretion of organic anions and cations. Physiol Rev 73:765–796

PubMed  CAS  Google Scholar 

Pulliam JD, Seward RL, Henry RT, Steinberg SA (1985) Investigating ivermectin toxicity in Collies. Vet Med 80:33–40

Google Scholar 

Roninson IB, Chin JE, Choi KG, Gros P, Housman DE, Fojo A, Shen DW, Gottesman MM, Pastan I (1986) Isolation of human mdr DNA sequences amplified in multidrug resistant KB carcinoma cells. Proc Natl Acad Sci U S A 83:4538–4542

PubMed  CAS  Google Scholar 

Rosenberg T, Wilbrandt W (1957) Uphill transport induced by counterflow. J Gen Physiol 41:289–296

PubMed  CAS  Google Scholar 

Rost D, Kartenbeck J, Keppler D (1999) Changes in the localization of the rat canalicular conjugate export pump Mrp2 in phalloidin-induced cholestasis. Hepatology 29:814–821

PubMed  CAS  Google Scholar 

Roulet A, Puel O, Gesta S, Lepage JF, Drag M, Soll M, Alvinerie M, Pineau T (2003) MDR1-deficient genotype in Collie dogs hypersensitive to the P-glycoprotein substrate ivermectin. Eur J Pharmacol 460:85–91

PubMed  CAS  Google Scholar 

Russel FG, Masereeuw R, Van Aubel RA (2002) Molecular aspects of renal anionic drug transport. Annu Rev Physiol 64:563–594

PubMed  CAS  Google Scholar 

Scheffer GL, Kool M, de Haas M, de Vree JM, Pijnenborg AC, Bosman DK, Oude Elferink R, Van Borst P, Scheper RJ (2002) Tissue distribution and induction of human multidrug resistant protein 3. Lab Invest 82:193–201

PubMed  CAS  Google Scholar 

Schwab M, Schaeffeler E, Marx C, Fromm MF, Kaskas B, Metzler J, Stange E, Herfarth H, Schoelmerich J, Gregor M, Walker S, Cascorbi I, Roots I, Brinkmann U, Zanger UM, Eichelbaum M (2003) Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitis. Gastroenterology 124:26–33

PubMed  CAS  Google Scholar 

Sekine T, Watanabe N, Hosoyamada M, Kanai Y, Endou H (1997) Expression cloning and characterization of a novel multispecific organic anion transporter. J Biol Chem 272:18526–18529

PubMed  CAS  Google Scholar 

Semenza G, Kinne R (1985) (eds) Membrane transport driven by ion gradients. Ann N Y Acad Sci 456:459

Shibayama Y, Ikeda R, Motoya T, Yamada K (2004) St John’s Wort (Hypericum perforatum) induces overexpression of multidrug resistance protein2 (MRP2) in rats: a 30-day ingestion study. Food Chem Toxicol 42:995–1002

PubMed  CAS  Google Scholar 

Shoda J, Kano M, Oda K, Kamiya J, Nimura Y, Suzuki H, Sugiyama Y, Miyazaki H, Todoroki T, Stengelin S, Kramer W, Matsuzaki Y, Tanaka N (2001) The expression levels of plasma membrane transporters in the cholestatic liver of patients undergoing biliary drainage and their association with the impairment of biliary secretory function. Am J Gastroenterol 96:3368–3378

PubMed  CAS  Google Scholar 

Siegsmund M, Brinkmann U, Schaffeler E, Weirich G, Schwab M, Eichelbaum M, Fritz P, Burk O, Decker J, Alken P, Rothenpieler U, Kerb R, Hoffmeyer S, Brauch H (2002) Association of the P-glycoprotein transporter MDR1(C3435T) polymorphism with the susceptibility to renal epithelial tumors. J Am Soc Nephrol 13:1847–1854

PubMed  CAS  Google Scholar 

Smith JN, Williams RT (1949) The metabolism of phenacetin (p-ethoxyacetanilide) in the rabbit and a further observation on acetanilide metabolism. Biochem J 44:239–242

CAS  Google Scholar 

Soroka CJ, Lee JM, Azzaroli F, Boyer JL (2001) Cellular localization and up-regulation of multidrug resistance-associated protein 3 in hepatocytes and cholangiocytes during obstructive cholestasis in rat liver. Hepatology 33:783–791

PubMed  CAS  Google Scholar 

Spahn-Langguth H, Baktir G, Radschuweit A, Okyar A, Terhaag B, Ader P, Hanafy A, Langguth P (1998) P-glycoprotein transporters and the gastrointestinal tract: evaluation of the potential in vivo relevance of in vitro data employing talinolol as model compound. Int J Clin Pharmacol Ther 36:16–24

PubMed  CAS  Google Scholar 

Sperber I (1959) Secretion of organic anions in formation of urine and bile. Pharmacol Rev 11:109–134

PubMed  CAS  Google Scholar 

Stein W (1967) (ed) The movement of molecules across membranes. Academic Press, New York, pp 367

Google Scholar 

Sweet DH, Wolff NA, Pritchard JB (1997) Expression cloning and characterization of ROAT1 The basolateral organic anion transporter in rat kidney. J Biol Chem 272:30088–30095

PubMed  CAS  Google Scholar 

Synold TW, Dussault I, Forman BM (2001) The orphan nuclear receptor SXR coordinately regulated drug metabolism and efflux. Nature Med 7:584–590

PubMed  CAS  Google Scholar 

Tirona RG, Kim RB (2002) Pharmacogenomics of drug transporters. In: J Licinio, M-L Wing (eds) Pharmacogenomics: the search for individualized therapies. Wiley-VCH, pp 179–213

Tirona RG, Leake BF, Merino G, Kim RB (2001) Polymorphisms in OATP-C: Identification of multispecific allelic variants associated with altered transport activity among European- and African-Americans. J Biol Chem 276:35669–35675

PubMed  CAS  Google Scholar 

Trauner M, Boyer JL (2003) Bile salt transporters: molecular characterization, function, and regulation. Physiol Rev 83:633–671

PubMed  CAS  Google Scholar 

Trauner M, Meier PJ, Boyer JL (1998) Molecular pathogenesis of cholestasis. N Engl J Med 339:1217–1227

PubMed  CAS  Google Scholar 

Trauner M, Wagner M, Fickert P, Zollner G (2005) Molecular regulation of hepatobiliary transport systems: clinical implications for understanding and treating cholestasis. J Clin Gastroenterol 39:S111–S124

PubMed  Google Scholar 

Ullrich KJ (1997) Renal transporters for organic anions and organic cations. Structural requirements for substrates. J Membr Biol 158:95–107

PubMed  CAS  Google Scholar 

Van Heeswijk RP, Veldkamp A, Mulder JW, Meenhorst PL, Lange JM, Beijnen JH, Hoetelmans RM (2001) Combination of protease inhibitors for the treatment of HIV-1-infected patients: a review of pharmacokinetics and clinical experience. J Antivir Ther 6:201–229

Google Scholar 

Van Montfoort JE, Hagenbuch B, Groothuis GMM, Koepsell H, Meier PJ, Meijer DKF (2003) Drug uptake systems in liver and kidney. Curr Drug Metab 4:185–211

PubMed  Google Scholar 

Wagner M, Trauner M (2005) Transcriptional regulation of hepatobiliary transport systems in health and disease: implications for a rationale approach to the treatment of intrahepatic cholestasis. Ann Hepatol 4:77–99

PubMed  CAS  Google Scholar 

Wandel C, Kim RB, Kajiji S, Guengerich FP, Wilkinson GR, Wood AJJ (1999) P-glycoprotein and cytochrome P-450 3 A inhibition: dissociation of inhibitory potencies. Cancer Res 59:3944–3948

PubMed  CAS  Google Scholar 

Ward WJ III (1970) Electrically induced carrier transport. Nature 227:162–163

PubMed  CAS  Google Scholar 

Washington CB, Wiltshire HR, Man M, Moy T, Harris SR, Worth E, Weigl P, Liand Z, Hall D, Marriot L, Blaschke TF (2000) The disposition of saquinavir, in normal and P-glycoprotein deficient mice, rats, and cultured cells. Drug Metab Disp 28:1058–1062

CAS  Google Scholar 

Watson P, Jones AT, Stephens DJ (2005) Intracellular trafficking pathways and drug delivery: fluorescence imaging of living and fixed cells. Adv Drug Deliv Rev 57:43–61

PubMed  CAS  Google Scholar 

Weaver JL, Pine PS, Aszalos A, Schoenlein PV, Currier SJ, Padmanabhan R, Gottesman MM (1991) Laser scanning and confocal microscopy of daunorubicin, doxorubicin, and rhodamine 123 in multi-drug resistant cells. Exp Cell Res 196:323–329

PubMed  CAS  Google Scholar 

Westphal K, Weinbrenner A, Zschiesche M, Franke G, Knoke M, Oertel R, Fritz P, von Richter O, Warzok R, Hachenberg T, Kaumann HM, Schrenk D, Terhaag B, Kroemer HK, Siegmund W (2000) Induction of P-glycoprotein by rifampin increases intestinal secretion of talinolol in human beings: a new type of drug/drug interaction. Clinical Pharmacol Ther 68:345–355

CAS  Google Scholar 

Wilbrandt W (1975) Criteria in carrier transport. In: H Eisenberg, E Katchalski-Kazir, LA Manson (eds) Biomembranes vol 7. Plenum Press New York, London, pp 11–31

Google Scholar 

Williams RT (1959) (ed) Detoxification mechanisms the metabolism and detoxification of drugs, toxic substances and other organic compounds. Chapman & Hall, London, pp 796

Google Scholar 

Wright EM, Turk E (2004) The sodium/glucose cotransport family SLC5. Pflügers Arch-Eur J Physiol 447:510–518

CAS  Google Scholar 

Yarim M, Moro S, Huber R, Meier PJ, Kaseda C, Kashima T, Hagenbuch B, Folkers G (2005) Application of QSAR analysis to organic anion polypeptide 1a5 (Oatp 1a5) substrates. Bioorg Med Chem 13:463–471

PubMed  CAS  Google Scholar 

Zhang Y, Guo X, Tin ET, Benet LZ (1998) Overlapping substrate specificities of cytochrome P450 3A and P-glycoprotein for a novel cysteine protease inhibitor. Drug Metab Disp 26:360–366

CAS  Google Scholar 

Ziegler K, Hummelsiep S (1993) Hepatoselective carrier-mediated sodium-independent uptake of pravastatin and pravastatin-lactone. Biochim Biophys Acta 1153:23–33

PubMed  CAS  Google Scholar 

Ziegler K, Stünkel W (1992) Tissue-selective action of pravastatin due to hepatocellular uptake via a sodium-independent bile acid transporter. Biochim Biophys Acta 1139:203–209

PubMed  CAS  Google Scholar